Skip to main content
Clinical Trials/NL-OMON41540
NL-OMON41540
Recruiting
Phase 4

A Multicenter, Prospective, Long-term Registry of Pediatric Patients with Crohn*s Disease and Ulcerative Colitis - Registry REMICADE PIB4002

Janssen Biologics BV0 sites200 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Crohn's disease
Sponsor
Janssen Biologics BV
Enrollment
200
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Have a confirmed diagnosis of CD or ulcerative colitis for at least 2 months.
  • 2\. Are male or female at least 6 years of age, but less than 17 years of age with the exception of
  • patients who participated in the Sponsor\*s Protocol C0168T72 or C0168T62 and
  • are 17 years of age or older. These patients are eligible for enrollment in this registry regardless of
  • the patient's age at the time of enrollment.
  • 3\. The parent/legal guardian must be capable of providing written informed consent,
  • and assent should be obtained from the child according to local regulations (age at
  • which assent is given may vary by the IRB or EC).
  • 4\. The patient\*s physician expects the patient to be scheduled for a medical
  • encounter (and/or other direct contact) at least every 6 months, as part of their

Exclusion Criteria

  • 1\. Are less than 6 years of age or 17 years of age or older with the exception of
  • patients who participated in the Sponsor\*s Protocol C0168T72 or C0168T62 and
  • are 17 years of age or older.
  • 2\. The patient and parent/guardian are not able to adhere to the protocol
  • requirements.
  • 3\. Have other Crohn\*s\-like diseases that are associated with genetic diseases (eg,
  • glycogen storage disease).
  • 4\. Are participating in any clinical trial for an investigational agent that is not
  • commercially available.
  • 5\. Are currently participating in one of the sponsors trials for pediatric IBD (eg,

Outcomes

Primary Outcomes

Not specified

Similar Trials